The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

nucleic acid-based tests offer advantages in early detection and sensitivity. There are different methods used in molecular diagnostic assays, including isothermal amplification for at home ...

thanks to early diagnosis with new assays. “Seegene’s technologies will provide new insights on PCR-based tests beyond the development of diagnostic products, accelerating the development of ...

closed-tube system that allows for real time quantitative PCR without sample processing or electrophoresis. At the core of the system is a 5' nuclease assay conducted with the TaqMan¨ PCR Reagent Kit ...

Our expert speaker will explore the need to progress from the one-assay-one-gene paradigm, how to include quality control ...

The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, today, at the 43rd annual J.P. Morgan Healthcare Conference. In addition to ...

The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease.